Transgenic livestock made easy

Trends in Biotechnology

Volumn 22, Issue 4, 2004, Pages 157-159

  Whitelaw, C Bruce A ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FARMS; GENE TRANSFER;

FARM ANIMALS; TRANSGENESIS;

BIOTECHNOLOGY;

BIOTECHNOLOGY; GENETICALLY MODIFIED ORGANISM; LIVESTOCK;

BIOTECHNOLOGY; COST EFFECTIVENESS ANALYSIS; DNA DETERMINATION; DNA TRANSFER; DOMESTIC ANIMAL; GENE EXPRESSION; GENE TRANSFER; GERM LINE; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRINAE; LIVESTOCK; METHODOLOGY; MICROINJECTION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; SWINE; TRANSGENE; TRANSGENIC ANIMAL; TRANSGENICS;

ANIMALS; ANIMALS, DOMESTIC; ANIMALS, GENETICALLY MODIFIED; GENETIC ENGINEERING; LENTIVIRUS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS; SUS SCROFA;

EID: 1642291044     PISSN: 01677799     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tibtech.2004.02.005     Document Type: Short Survey

References (16)

1. Hammer R.E., et al. Production of transgenic rabbits, sheep and pigs by microinjection. Nature. 315:1985;680-683.
2. Harris A. Towards an ovine model of cystic fibrosis. Hum. Mol. Genet. 6:1997;2191-2194.
3. Denning C., et al. Deletion of the α(1,3)galactosyl transferase (GGTA1) gene and the prion protein (PrP) gene in sheep. Nat. Biotechnol. 19:2001;559-562.
4. Nottle M.B., et al. Effect of DNA concentration on transgenesis rates in mice and pigs. Transgenic Res. 10:2001;523-531.
5. Wright G., et al. High level expression of active human α-1-antitrypsin in the milk of transgenic sheep. Biotechnology. 9:1991;830-834.
6. Lavitrano M., et al. Efficient production by sperm-mediated gene transfer of human decay accelerating factor (hDAF) transgenic pigs for xenotransplantation. Proc. Natl. Acad. Sci. U. S. A. 99:2002;14230-14235.
7. Wilmut I., et al. Viable offspring derived from fetal and adult mammalian cells. Nature. 385:1997;810-813.
8. Hofmann A., et al. Efficient transgenesis in farm animals by lentiviral vectors. EMBO Rep. 4:2003;1054-1060.
9. Rohll J.B., et al. Design, production, safety, evaluation and clinical applications of nonprimate lentiviral vectors. Methods Enzymol. 346:2002;466-500.
10. Lois C., et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science. 295:2002;868-872.
11. Pfeifer A., et al. Transgenesis by lentiviral vectors: lack of gene silencing in mammalian embryonic stem cells and preimplantation embryos. Proc. Natl. Acad. Sci. U. S. A. 99:2002;2140-2145.
12. Chan A.W., et al. Transgenic cattle produced by reverse-transcribed gene transfer in oocytes. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14028-14033.
13. Thomas C.E., et al. Progress and problems with the use of viral vectors for gene therapy. Nat. Rev. Genet. 4:2003;346-358.
14. Tiscornia G., et al. A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc. Natl. Acad. Sci. U. S. A. 100:2003;1844-1848.
15. Rubinson D.A., et al. A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33:2003;401-406.
16. Clark A.J., Whitelaw C.B.A. A future for transgenic livestock. Nat. Rev. Genet. 4:2003;825-833.